PF-3716539

N/A

Report date: 2022/07/19 16:22:54

NME

Base Information

Drug NamePF-3716539

Drug Alias NamePF-3716539PF-03716539

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A